Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Therapy and Kinetics of Inflammatory Markers
NCT02536248Phase 3Completed
- Sponsor
- Université Laval
- Start
- Aug 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Université Laval. Started Aug 2015; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02536248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536248.